Concepedia

Lucy T. Xu

LT

Statistics

Publications

14

Citations

365

H-Index

11

Active since

2014

Affiliations

Cleveland Eye Clinic(Current)

Cleveland Clinic

Emory University

The University of Texas MD Anderson Cancer Center

Eisai (United States)

Lucy T. Xu is an author at Cleveland Eye Clinic specializing in medicine, surgery, and diabetic retinopathy.

ORCID

Top concepts

Publications per year

2014–2022

14

Publications

14

Phase I Dose-Escalation Study of the Multikinase Inhibitor Lenvatinib in Patients with Advanced Solid Tumors and in an Expanded Cohort of Patients with Melanoma

David S. Hong, Razelle Kurzrock, Jennifer J. Wheler et al. · Clinical Cancer Research · 2015 · 69 citations · Full text

First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE<sub>2</sub>-receptor E-type 4 (EP4), in patients with advanced cancers

David S. Hong, Aparna R. Parikh, Geoffrey I. Shapiro et al. · Journal for ImmunoTherapy of Cancer · 2020 · 69 citations · Full text

Patient-Reported Complications after Intravitreal Injection and Their Predictive Factors

Michael S. Ramos, Lucy T. Xu, Srinidhi Singuri et al. · Ophthalmology Retina · 2020 · 52 citations · Full text

, , +4

Uveal Melanoma Metastatic to the Liver: Treatment Trends and Outcomes

Lucy T. Xu, Pauline Funchain, James Bena et al. · Ocular Oncology and Pathology · 2019 · 24 citations · Full text

Phase 1b study of lenvatinib (E7080) in combination with temozolomide for treatment of advanced melanoma

David S. Hong, Razelle Kurzrock, Gerald S. Falchook et al. · Oncotarget · 2015 · 23 citations · Full text

1–5 of 14